1. Introduction {#sec1-ijms-20-03904}
===============

Lipid rafts are dynamic ordered nanoscale assemblies in the plasma membrane and other intracellular membranes, and are enriched in cholesterol and glycosphingolipids \[[@B1-ijms-20-03904],[@B2-ijms-20-03904]\]. They are characterized by the presence of proteins with lipid modifications, as well as proteins involved in signal transduction. Due to their composition, they are resistant to solubilization in nonionic mild detergents \[[@B1-ijms-20-03904],[@B3-ijms-20-03904]\]. Lipid raft components can diffuse laterally in the plasma membrane, thus lipid raft microdomains have the ability to associate and dissociate on a subsecond timescale, and vary in stability, size, shape, lifetime, and molecular composition \[[@B3-ijms-20-03904],[@B4-ijms-20-03904],[@B5-ijms-20-03904]\]. The compartmentalization of molecules into lipid rafts provides a favorable environment to facilitate interactions among the raft components. Therefore, lipid rafts act as platforms to segregate lipids, receptors, adaptors, kinases, scaffolding proteins, and cytoskeletal apparatus that trigger complex events and coordinate diverse biological processes \[[@B2-ijms-20-03904],[@B6-ijms-20-03904],[@B7-ijms-20-03904],[@B8-ijms-20-03904],[@B9-ijms-20-03904],[@B10-ijms-20-03904]\].

Since the total protein content of lipid rafts can be extensive, these microdomains are an attractive target for mass-spectrometry (MS)-based proteomics. Proteomic strategies have been applied to lipid rafts from a variety of tissue and cell types, including rat brain \[[@B11-ijms-20-03904]\], Hella cells \[[@B12-ijms-20-03904]\], ovarian cancer cells \[[@B13-ijms-20-03904]\], and immune cells, such as neutrophils \[[@B14-ijms-20-03904],[@B15-ijms-20-03904]\], monocytes \[[@B16-ijms-20-03904]\], and macrophages \[[@B17-ijms-20-03904]\], as well as lymphocytes T \[[@B18-ijms-20-03904],[@B19-ijms-20-03904]\], B \[[@B20-ijms-20-03904]\], and natural killer cells \[[@B21-ijms-20-03904]\], with the aim of better identifying the proteins present in lipid rafts \[[@B22-ijms-20-03904],[@B23-ijms-20-03904],[@B24-ijms-20-03904],[@B25-ijms-20-03904]\]. Functional proteomic analysis of lipid raft proteins examines the relationship between individual proteins and clusters them based on characteristics such as structure, localization, binding partners, and post translational modification, which has led to the elucidation of novel molecular pathways and biological events coordinated by these membrane microdomains \[[@B23-ijms-20-03904],[@B25-ijms-20-03904],[@B26-ijms-20-03904],[@B27-ijms-20-03904]\].

Mast cells (MCs) are multifunctional immune cells that, in addition to their well-established role in allergic and anaphylactic reactions, are implicated in innate and adaptive immunity, and in inflammation among other physiological and pathological processes \[[@B28-ijms-20-03904],[@B29-ijms-20-03904],[@B30-ijms-20-03904]\]. Lipid rafts modulate many important biological processes related to these MC functions, such as degranulation, endocytosis, play a role in MC development and recruitment, and contribute to the preservation of MC structure and organization \[[@B6-ijms-20-03904],[@B31-ijms-20-03904],[@B32-ijms-20-03904],[@B33-ijms-20-03904]\]. However, there is no MC lipid raft proteome available. Only a few studies report on the whole MC plasma membrane composition, using MS for lipid characterization \[[@B34-ijms-20-03904]\] or protein identification using MALDI-TOF (matrix-assisted laser desorption/ionization and time-of-flight) or LC-MS/MS (liquid chromatography-mass spectrometry) \[[@B35-ijms-20-03904],[@B36-ijms-20-03904],[@B37-ijms-20-03904]\]. Moreover, only a limited number of proteins have been annotated and a non-detailed functional analysis was performed.

The present study was undertaken to investigate the qualitative proteomic profile of MC lipid rafts using the rat mucosal MC line RBL-2H3. While the investigation of lipid rafts in MCs has largely been done using RBL-2H3 MCs \[[@B38-ijms-20-03904]\], there is no proteomic profile of lipid rafts from RBL-2H3 MCs or any other MC. Although controversy exists over the exact character of RBL-2H3 MCs \[[@B39-ijms-20-03904],[@B40-ijms-20-03904]\], they are still a widely accepted model for functional studies of MC dynamics. Since the RBL-2H3 MC line was first identified in 1973 \[[@B41-ijms-20-03904]\], and later cloned and characterized \[[@B42-ijms-20-03904]\], it has become one the most commonly used models to study MC function \[[@B40-ijms-20-03904]\]. RBL-2H3 MCs provide many advantages over primary MCs. They may be grown in large amounts in culture and can easily be genetically manipulated. RBL-2H3 MCs have also been used to study signaling pathways following FcεRI (high-affinity IgE receptor) activation and MC regulated exocytosis, events in which lipid rafts are involved. More recently, RBL-2H3 MCs have also been used as a model for studies focused on the detection of allergens, diagnosis of allergic sensitization, and vaccine safety studies \[[@B40-ijms-20-03904]\]. Even considering the problem of MC heterogeneity, the findings provided by RBL-2H3 MCs have substantially contributed to a global understanding of MC function. The results of the present investigation show that the methods applied here were efficient in identifying lipid raft proteins in MCs and these raft microdomains are involved in the regulated secretion, organization, and stabilization of macromolecular complexes, as well as signaling transduction pathways important to MC biological functions. This qualitative proteomic data should provide a more complete understanding of lipid rafts in MC biology.

2. Results {#sec2-ijms-20-03904}
==========

2.1. Obtention of Lipid Rafts from RBL-2H3 Mast Cells {#sec2dot1-ijms-20-03904}
-----------------------------------------------------

Lipid rafts were isolated from RBL-2H3 MCs using discontinuous sucrose-density gradient ultracentrifugation. LAT1 (linker for activation of T-cells 1), a lipid-raft-specific protein in immune cells \[[@B43-ijms-20-03904],[@B44-ijms-20-03904]\], was used as a marker for the lipid rafts. Using immunoblotting, LAT1 was highly enriched in Fractions 2 and 3. In addition, the SFK (Src family kinase) Lyn, and the rodent MC-specific GD1b-derived gangliosides, both well-characterized MC lipid raft components \[[@B45-ijms-20-03904],[@B46-ijms-20-03904]\], were also enriched in Fractions 2 and 3 ([Figure 1](#ijms-20-03904-f001){ref-type="fig"}). Additionally, Flotillin-1, a widely used marker of lipid rafts \[[@B8-ijms-20-03904]\], was also concentrated in Fractions 2 and 3. Thus, Fractions 2 and 3 represent the lipid raft fractions in these preparations. In contrast, Histone H3, a nuclear protein, was concentrated in Fractions 9 and 10.

2.2. Identification of Mast Cell Lipid Raft Proteins Using Nano-UPLC-MS^E^ {#sec2dot2-ijms-20-03904}
--------------------------------------------------------------------------

The lipid raft fractions (Fractions 2 and 3) obtained from three independent experiments were pooled. The resulting sample was divided and used for two different post-isolation treatment methods, Method I (MetI) and Method II (MetII). MetI eliminated the sucrose from the enriched lipid raft fractions prior to MS analysis. MetII was harsher than MetI and involved mixing the sample with OGP (octyl β-glucopyranoside) detergent followed by a final methanol-chloroform extraction. The solubilized proteins obtained from the lipid raft fractions after the post-isolation treatments were submitted to nano-UPLC-MS^E^ analysis. The samples were run in three technical replicates and only proteins identified in two out of the three replicates were considered for further analysis. The obtained UPLC-MS^E^ protein data generated by the PLGS was processed to verify the quality of the proteomic analysis ([Figure S1](#app1-ijms-20-03904){ref-type="app"}: Dynamic range of the proteomic analysis). For reliable protein identification, a reverse sequence database of Rattus norvegicus was used to calculate the false rate. The false positive rates of proteins obtained from MetI and MetII were, respectively, 1.04% and 0.36%. [Supplementary Figure S1](#app1-ijms-20-03904){ref-type="app"} depicts the results obtained from an analysis of the dynamic range indicating that a 3 log difference in abundance and a good distribution of both high and low concentrations of the proteins were obtained with both methods. This approach ensured the selection of highly representative proteins.

After processing, according to the criteria stated in [Section 5.6](#sec5dot6-ijms-20-03904){ref-type="sec"}, 429 proteins were identified in MetI ([Table S1](#app1-ijms-20-03904){ref-type="app"}: Detailed annotation of proteins identified in Method I), and 753 in MetII ([Table S2](#app1-ijms-20-03904){ref-type="app"}: Detailed annotation of proteins identified in Method II); 196 proteins were exclusively identified in MetI and 520 proteins were exclusively identified in MetII, and 233 proteins were common between the methods. In total, 949 proteins were identified ([Figure 2](#ijms-20-03904-f002){ref-type="fig"}) ([Table S3](#app1-ijms-20-03904){ref-type="app"}: Detailed annotation of proteins identified in Methods I and II).

2.3. Characterization of Mast Cell Lipid Raft Proteins {#sec2dot3-ijms-20-03904}
------------------------------------------------------

The 949 identified proteins were then analyzed to determine whether they had been previously reported as lipid raft proteins or had characteristic modifications of lipid raft proteins. Of the 949 identified proteins, 855 (≈90%; 855/949) were found in the RaftProtV2 database as previously reported lipid raft proteins \[[@B26-ijms-20-03904]\], while 94 of the proteins had not been previously annotated ([Table S4](#app1-ijms-20-03904){ref-type="app"}: Mast cell lipid raft proteins absent from RaftProtV2 database, and [Figure S2](#app1-ijms-20-03904){ref-type="app"}: Immuno-blot analysis of the β-subunit of FcεRI from RBL-2H3 MC lipid rafts). Of the previously annotated proteins, 172 were unique to MetI and 454 to MetII, thus indicating that MetII was more efficient in extracting lipid raft proteins ([Table S5](#app1-ijms-20-03904){ref-type="app"}: Mast cell lipid raft proteins analyzed by RafProtV2 database). A total of 570 (≈67%; 570/855) of these proteins were classified as high-confidence lipid raft proteins based on experimental evidence according to the RaftProtV2 database, confirming that these proteins were indeed lipid raft proteins. The proteins with the highest number of citations supported by experimental evidence are listed in [Table 1](#ijms-20-03904-t001){ref-type="table"}.

Lipid modifications are one of the characteristics of lipid-raft-associated proteins \[[@B1-ijms-20-03904]\]. Therefore, all the identified proteins were examined for lipid modifications using bioinformatic analysis. Almost half of the identified proteins (46.8%; 444/949) had at least one lipid modification: S-palmitoylation, isoprenylation, N-myristoylation, or GPI (glycophosphatidylinositol) anchor. There was basically no difference in the percentage of proteins with lipid modifications extracted with either MetI (50.3%; 216/429) or MetII (48%; 361/753). However, MetII had a higher number of proteins with lipid modification in all categories analyzed ([Figure 3](#ijms-20-03904-f003){ref-type="fig"}).

Proteins with transmembrane domains are also known to be targeted to lipid rafts \[[@B47-ijms-20-03904],[@B48-ijms-20-03904]\]. The presence of a transmembrane domain was predicted in all proteins identified by both methods using TMHMM server version 2.0 ([Figure 4](#ijms-20-03904-f004){ref-type="fig"}A,B). The common group of proteins contained a sizeable number of proteins with transmembrane domains (27%; 63/233). Few (7.14%; 14/196) unique proteins in MetI had transmembrane domains, and only four of these unique proteins had two or more transmembrane domains. In contrast, the majority (52%; 274/520) of the unique proteins obtained using MetII contained at least one transmembrane domain. Furthermore, the unique proteins isolated by MetII had a higher number of transmembrane domain/protein in comparison to the common proteins or unique proteins identified with MetI. Thus, MetII was more efficient at extracting proteins with transmembrane domains.

2.4. Functional Characterization of Mast Cell Lipid Raft Proteome {#sec2dot4-ijms-20-03904}
-----------------------------------------------------------------

Initially, all identified proteins from both MetI and MetII were used for global proteomic analysis. The 949 proteins were annotated according to the three classes of biological domains (cellular component, biological processes, and molecular function) from Gene Ontology (GO) using the Software Tool for Researching Annotations of Proteins (STRAP) \[[@B49-ijms-20-03904]\]. In the cellular component class, 13% of the proteins were associated with the GO terms plasma membrane (11%) and cell surface (2%). Terms associated with cytoplasm (10%), other intracellular organelles (11%), endoplasmic reticulum (9%), mitochondria (6%), and cytoskeleton (5%) were also highly represented ([Figure 5](#ijms-20-03904-f005){ref-type="fig"}A). In the GO class biological processes, the largest groups were proteins categorized by their involvement in regulation (26%) and cellular process (24%). The terms localization (13%) and response to stimulus (10%) were also highly represented ([Figure 5](#ijms-20-03904-f005){ref-type="fig"}B). Finally, in the molecular function class, the GO terms binding (48%), catalytic activity (30%), and structural molecular activity (8%) were the most frequent ([Figure 5](#ijms-20-03904-f005){ref-type="fig"}C).

2.5. Distribution among GO Domains of the Mast Cell Lipid Raft Proteins Identified Using Different Post-Isolation Methods {#sec2dot5-ijms-20-03904}
-------------------------------------------------------------------------------------------------------------------------

In order to evaluate the differences between the methods, the identified proteins were divided into unique groups for each method and the common group. The proteins were analyzed according to the three classes of biological domains from GO by STRAP \[[@B49-ijms-20-03904]\]. In the GO cellular component class, the unique MetI proteins had a higher percentage of proteins linked to the GO terms: cytoplasm, nucleus, and other. The unique MetII proteins had a higher percentage in cytoplasm, endoplasmic reticulum, other, other intracellular organelles, and plasma membrane. Moreover, the comparison between the methods showed an approximately 1.2--2.5-fold increase in unique MetII proteins linked to the terms endoplasmic reticulum, endosome, other, other intracellular organelles, and plasma membrane. The common group showed a high percentage of proteins associated with the terms nucleus, other, and plasma membrane ([Figure 6](#ijms-20-03904-f006){ref-type="fig"}A). The MetII unique proteins were distributed in practically all the terms in the cellular component in GO. The distribution of the MetII unique proteins with transmembrane domains was practically identical ([Figure S3](#app1-ijms-20-03904){ref-type="app"}: Total identified proteins and unique MetII proteins with transmembrane domains (TMD) have a similar distribution in the cellular component GO class). In the biological processes GO class, there was an increased percentage of unique proteins from MetI associated with the terms cellular process, other, regulation, and response to stimulus. With MetII the highest percentage of proteins were associated with the terms cellular process, localization, other, and regulation. Among the common proteins, the highest percentage of proteins were associated with the terms cellular process, localization, other, regulation, and response to stimulus ([Figure 6](#ijms-20-03904-f006){ref-type="fig"}B). In the molecular function class, there was an increased percentage of unique proteins isolated with MetI associated with the terms binding, catalytic activity, and other. With MetII, the highest percentage of proteins were associated with the terms binding, catalytic activity, and other. In the common group, the highest percentage of proteins was associated with the terms binding, catalytic activity, and other ([Figure 6](#ijms-20-03904-f006){ref-type="fig"}C). The identified proteins were also analyzed by the highest percentage within each term ([Table 2](#ijms-20-03904-t002){ref-type="table"}). These analyses demonstrate that functionally, the identified proteins were consistent with their being lipid raft components. Moreover, there was no bias between MetI or MetII as each method was associated with 10 GO terms and the common proteins were associated with 8 GO terms. However, the highest percent of proteins associated with a given GO term differed between the methods.

2.6. Functional Enrichment of the Mast Cell Lipid Raft Proteins {#sec2dot6-ijms-20-03904}
---------------------------------------------------------------

It is also important in proteomic studies to provide a functional assessment of the identified proteins for further system studies. Therefore, the functional relationship among the proteins identified in the MC lipid raft proteome was assessed. An analysis was carried out using the data from *Rattus norvegicus* proteins available in the DAVID Bioinformatics Resources database \[[@B50-ijms-20-03904]\]. Many functional groups were identified in this proteome data. These groups were based on the enrichment score, the number of annotated proteins in each GO term, Fisher exact *p*-value, and false discovery rate (FDR) ([Table S6](#app1-ijms-20-03904){ref-type="app"}: Enriched GO terms from mast cell lipid raft proteome analysis using DAVID Bioinformatic Resources). The groups with higher enrichment scores are shown in [Figure 7](#ijms-20-03904-f007){ref-type="fig"}. The terms associated with the highest group enrichment score were extracellular vesicle, extracellular exosome, membrane-bound vesicle, and extracellular regions; these terms are all consistent with a localization on or near the plasma membrane. However, the group with the highest fold enrichment was associated with the terms mast cell degranulation, leukocyte degranulation, and MC activation involved in immune response. Other significantly enriched single terms that were not grouped were membrane protein complex, membrane organization, membrane-bounded organelle, cytoskeleton organization, and biological adhesion ([Figure 7](#ijms-20-03904-f007){ref-type="fig"}). This analysis showed that based on the terms encompassed in the enriched groups, as well as the isolated terms, that proteins associated with processes such as vesicle-mediated secretion by immune cells, membrane associated protein localization and stabilization, and immune cell signaling response were significantly enriched in the MC lipid raft proteome.

3. Discussion {#sec3-ijms-20-03904}
=============

This proteomic study provides a comprehensive description of the protein composition of RBL-2H3 MC lipid rafts. It provides evidence that the use of two methods to extract lipid raft proteins increases the proteome coverage and improves the identification of integral and associated lipid raft proteins. These proteins are involved in various aspects of MC function, especially those related to MC secretion, organization and stabilization of macromolecules complexes, and signal transduction.

Although the structure, composition, and functional roles of lipid rafts has been extensively investigated in many cell types, there is no universal protocol for the isolation and enrichment of these microdomains \[[@B24-ijms-20-03904],[@B25-ijms-20-03904],[@B26-ijms-20-03904]\]. The lack of a universal protocol for lipid raft isolation stems from the controversy over the biochemical aspects of raft microdomains, such as their instability, size, and highly dynamic nature \[[@B2-ijms-20-03904],[@B51-ijms-20-03904],[@B52-ijms-20-03904]\]. However, the solubilization of whole samples with nonionic mild detergents, such as Triton X-100 at low temperature, followed by sucrose density gradient centrifugation and the recovery of the detergent resistant membranes (DRMs) from the light fractions of the gradient, is the most commonly used method to obtain lipid rafts \[[@B13-ijms-20-03904],[@B18-ijms-20-03904],[@B22-ijms-20-03904],[@B51-ijms-20-03904],[@B53-ijms-20-03904],[@B54-ijms-20-03904],[@B55-ijms-20-03904]\]. This method requires careful interpretation, since differences in lipid raft isolation methods, such as type and concentration of the detergent, as well as the duration of the incubation, make results difficult to compare \[[@B21-ijms-20-03904],[@B56-ijms-20-03904]\]. Moreover, evidence suggest that microdomain fractions obtained using detergent-free methods are less enriched in lipid raft proteins than those prepared with detergents \[[@B57-ijms-20-03904]\].

The proteins found in the low-density fractions may be integral lipid raft constituents or associated with lipid raft components \[[@B23-ijms-20-03904],[@B44-ijms-20-03904],[@B47-ijms-20-03904],[@B48-ijms-20-03904],[@B58-ijms-20-03904]\]. Some of these proteins, such as LAT1, are known to be lipid raft components and serve as a guide to elucidate the contents and properties of these microdomains \[[@B23-ijms-20-03904],[@B43-ijms-20-03904],[@B44-ijms-20-03904]\]. Using LAT1 as a marker, the identification of lipid rafts in the low-density fractions of the sucrose gradient seen here is supported by previous results in RBL-2H3 MCs \[[@B6-ijms-20-03904],[@B59-ijms-20-03904],[@B60-ijms-20-03904],[@B61-ijms-20-03904],[@B62-ijms-20-03904]\] and in bone marrow-derived MCs (BMMCs) \[[@B63-ijms-20-03904]\]. However, in other cell types, other proteins, such as caveolin-1 \[[@B64-ijms-20-03904],[@B65-ijms-20-03904]\], flotillin-1 \[[@B64-ijms-20-03904],[@B66-ijms-20-03904],[@B67-ijms-20-03904]\], and CD-36 \[[@B56-ijms-20-03904]\], are often used to identify lipid rafts. The findings seen here, as well as those reported in the literature, confirm that Fractions 2 and 3 from RBL-2H3 MC homogenates are enriched in lipid rafts, and that these fractions may be pooled and used for proteomic characterization.

Numerous other studies have examined the lipid raft proteome in various cell types and tissues and form the basis of the RaftProtV2 database \[[@B25-ijms-20-03904]\]. The RaftProtV2 database has been used to compare proteomic data from previous studies with newly reported lipid raft proteomes. Other investigations have described a similar percentage of proteins already annotated in the RaftProtV2 database as was seen in the present study \[[@B12-ijms-20-03904],[@B13-ijms-20-03904],[@B68-ijms-20-03904],[@B69-ijms-20-03904]\]. Furthermore, it has been suggested that less than 25% of the total reported membrane raft proteins in the RafProtV2 database fall into the high confidence category \[[@B25-ijms-20-03904]\]. However, in the lipid raft proteome reported in this study, 65% of the proteins were high confidence raft proteins, indicating that the obtention and post-isolations methods used in this study resulted in an enriched lipid rafts fraction from MCs.

Part of the proteins identified in the present investigation had not been annotated in the RaftProtV2 database. However, some of the non-annotated proteins belonged to the same family of proteins as known lipid raft proteins. For example, although FcεRI subunit beta is absent from the RaftProtV2 database, the gamma subunit of the receptor is included \[[@B56-ijms-20-03904],[@B70-ijms-20-03904]\]. The current study confirmed the presence of the FcεRI subunit beta in MC lipid rafts using proteomic and immuno-blot analysis. FcεRI subunit beta had previously been reported as a component of MC lipid rafts using western blots and immunomicroscopy \[[@B6-ijms-20-03904],[@B62-ijms-20-03904],[@B63-ijms-20-03904]\]. Since the RaftProtV2 database does not contain any MC proteomes, not surprisingly, many of the RaftProtV2 non-annotated proteins are mainly expressed by MCs such as chymase, FcεRI subunit beta, mast cell carboxypeptidase A, and mast/stem cell growth factor receptor. Other non-annotated proteins are expressed by MCs and other immune cells, including arachidonate 5-lipoxygenase-activating protein, MHC class I, SAMNS1, macrophage stimulating 1 receptor, and interleukin-3 receptor subunit beta \[[@B71-ijms-20-03904],[@B72-ijms-20-03904]\].

The use of more than one method to extract proteins from the lipid raft fractions may yield a more complete recovery of proteins \[[@B25-ijms-20-03904]\]. Both MetI and MetII have been used extensively in other studies characterizing lipid raft proteomes from different tissues and cell types \[[@B1-ijms-20-03904],[@B3-ijms-20-03904],[@B12-ijms-20-03904],[@B14-ijms-20-03904],[@B73-ijms-20-03904],[@B74-ijms-20-03904]\]. In the present study, extraction of proteins from the lipid raft fractions using MetI or MetII resulted in the identification of proteins common to both methods, as well as proteins unique to each method. The differences observed between MetI and MetII may be explained, in part, by the distinct post-isolation treatment used in each method. The strategy applied in MetI eliminates the sucrose from the enriched lipid raft fractions prior to MS analysis \[[@B16-ijms-20-03904]\]. The procedure used in MetII mixes the sample with another detergent (OGP), followed by methanol-chloroform extraction, which aids in removing the interfering lipids that could be aggregated with the isolated proteins \[[@B73-ijms-20-03904],[@B74-ijms-20-03904]\]. Extraction using MetII yielded a higher number of total proteins, as well as those with lipid modifications typical of membrane raft proteins \[[@B1-ijms-20-03904],[@B47-ijms-20-03904]\].

Lipid modifications can be either permanent cotranslational additions or post-translational modifications \[[@B47-ijms-20-03904],[@B48-ijms-20-03904]\]. The main lipid modifications are S-palmitoylation, isoprenylation, N-terminal myristic acid tails, GPI-anchors, and cysteine acylation. Conjugation to lipids seems to be the most widespread and consistent factor in determining whether a protein will partition into lipid rafts \[[@B47-ijms-20-03904],[@B75-ijms-20-03904]\]. Moreover, the isolation and identification of transmembrane proteins represents one of the most difficult challenges for MS \[[@B25-ijms-20-03904]\]. However, extraction with chloroform/methanol used in MetII greatly improved the yield of the predicted transmembrane proteins. Transmembrane domains typically consist of α--helices or β--sheets, which favor the entry of the proteins into membrane rafts \[[@B48-ijms-20-03904],[@B76-ijms-20-03904]\]. MetII was more efficient in extracting proteins with lipid modification or transmembrane domains and is thus more suited toward providing MC lipid raft proteins for MS investigations. The post-isolation treatment used in MetII may expose a greater number of transmembrane proteins, thus making them available for trypsin digestion \[[@B74-ijms-20-03904]\] and allowing for their subsequent MS identification.

The importance of proteomic studies goes beyond a simple catalogue of the proteins present in a given sample. It also provides information on the functional relationships among the identified proteins. The Gene Ontology (GO) project provides for consistent descriptions of gene products found in different databases. The association of the lipid raft proteins with the GO class biological processes and molecular function showed that the MC lipid raft proteins are associated with terms consistent with the central role of lipid rafts in a number of important cellular events. The terms such as cellular process and catalytic activity can be correlated with the function of lipid rafts in protein processing \[[@B77-ijms-20-03904]\]. Moreover, the terms structural molecular activity, binding, and localization can be related to intracellular trafficking and sorting mechanisms \[[@B78-ijms-20-03904],[@B79-ijms-20-03904]\]. Additionally, the terms regulation and response to stimulus integrate the function of lipid rafts in diverse signal transduction pathways \[[@B6-ijms-20-03904],[@B7-ijms-20-03904],[@B32-ijms-20-03904],[@B80-ijms-20-03904]\].

In the analysis of the GO class cellular component, the proteins associated with terms other than plasma membrane may be explained in part by the fact that many proteins originally located in the cytoplasm or nucleus could be translocated and interact with plasma membrane constituents to form protein complexes \[[@B81-ijms-20-03904]\]. Moreover, lipid rafts may also be found in cellular compartments other than the plasma membrane such as in endoplasmic reticulum and mitochondria \[[@B55-ijms-20-03904],[@B74-ijms-20-03904],[@B82-ijms-20-03904],[@B83-ijms-20-03904],[@B84-ijms-20-03904]\]. Several lipids and proteins associated with lipid rafts are synthesized in the endoplasmic reticulum/Golgi apparatus before being transported to the plasma membrane \[[@B27-ijms-20-03904]\], where they may move laterally within the plasma membrane as well as traffic continuously between the plasma membrane and internal compartments \[[@B78-ijms-20-03904]\]. Finally, nuclear lipid microdomains are important in maintaining subnuclear structures and act as platforms for the transcription process during proliferation \[[@B85-ijms-20-03904]\].

In addition, within the cellular component class, five percent of the identified proteins were associated with the GO term cytoskeleton. The structure and organization of lipid rafts is tightly integrated with the cell cytoskeleton \[[@B7-ijms-20-03904],[@B13-ijms-20-03904],[@B19-ijms-20-03904],[@B62-ijms-20-03904]\]. Studies using live cell imaging have shown that the actin filaments are commonly co-localized with lipid rafts under a stimulus induced co-redistribution of raft components at the cell surface \[[@B86-ijms-20-03904]\]. Moreover, the dynamic rearrangement of the cytoskeleton in MCs following stimulation can act to stabilize the lipid raft clusters \[[@B6-ijms-20-03904],[@B62-ijms-20-03904],[@B87-ijms-20-03904],[@B88-ijms-20-03904]\].

The group with the highest enrichment score in the MC lipid raft proteome included the GO terms extracellular vesicle, membrane-bounded vesicle, extracellular exosome, and extracellular region. The terms that showed the greatest fold enrichment factor included the terms mast cell degranulation, leukocyte degranulation, and MC activation involved in immune response. Lipid rafts have ideal features for participating in intracellular membrane transport, acting as a crucial regulator of vesicle cargo and their consequent endocytosis and secretion \[[@B89-ijms-20-03904],[@B90-ijms-20-03904],[@B91-ijms-20-03904]\]. Notably, the hallmark of MC activation via FcεRI is the immediate release via highly regulated exocytosis (degranulation) of inflammatory mediators that are presynthesized and stored in MC secretory granules \[[@B92-ijms-20-03904],[@B93-ijms-20-03904]\]. Moreover, perturbation of the raft structure has a profound impact on FcεRI-mediated degranulation in MCs \[[@B6-ijms-20-03904],[@B62-ijms-20-03904],[@B94-ijms-20-03904]\].

The group with the next-highest enrichment score included proteins that were involved with the establishment of localization, protein localization, and macromolecular localization. Many of the proteins associated with these terms are adaptors or scaffolding proteins. These proteins then act as docking sites for signaling molecules in lipid raft domains forming a multicomponent assembly, which facilitates signal transduction in diverse pathways \[[@B88-ijms-20-03904],[@B95-ijms-20-03904]\]. Furthermore, other raft proteins identified in this study were also related to the signal transduction pathways in MCs. These proteins included CD45 (receptor-type tyrosine-protein phosphatase C), FcγRII (low affinity immunoglobulin Fc gamma receptor II), MC/stem cell growth factor receptor, IP~3~-receptor, integrins, phospholipid scramblase, serine/threonine-protein phosphatase PP1-alpha, protein-tyrosine phosphatase 1B, IQGAP1, calreticulin, calmodulin, DJ-1, RhoA, Gnai-2, and cdc42 \[[@B96-ijms-20-03904],[@B97-ijms-20-03904],[@B98-ijms-20-03904],[@B99-ijms-20-03904],[@B100-ijms-20-03904],[@B101-ijms-20-03904],[@B102-ijms-20-03904]\].

Another group with highly enriched scores included the GO terms membrane microdomain/raft and membrane region. Several transmembrane proteins, known to be associated with lipid rafts, were also identified in our MC proteome such as the flotillins and prohibitins. Other scaffold proteins, such as tetraspanins (CD81 and CD63) and the important transmembrane adaptor proteins (TRAPs) in immunoreceptor signaling LAT1 and NTAL (non-T cell activation linker; LAT2) \[[@B103-ijms-20-03904]\], were also identified in this lipid raft proteome. LAT1 and NTAL become rapidly phosphorylated in FcεRI-activation, resulting in its association with numerous signaling molecules \[[@B32-ijms-20-03904],[@B43-ijms-20-03904],[@B104-ijms-20-03904]\]. Moreover, these TRAPs are also involved in the regulation of MC morphology, adhesion, and chemotaxis \[[@B104-ijms-20-03904],[@B105-ijms-20-03904]\]. RACK1 (receptor for activated C kinase 1), a member of the tryptophan-aspartate repeat family of proteins, was also identified. RACK1 adopts a highly conserved seven-bladed β-propeller structure that serves as binding sites for multiple partners \[[@B106-ijms-20-03904],[@B107-ijms-20-03904]\]. Recently, RACK1 was identified as a crucial component of a multiprotein complex formed in T-cell lipid rafts upon TCR (T-cell antigen receptor) activation \[[@B108-ijms-20-03904]\]. Despite the significant role that RACK1 plays in shuttling and anchoring proteins and its involvement in immunoregulatory responses \[[@B107-ijms-20-03904],[@B108-ijms-20-03904],[@B109-ijms-20-03904]\], RACK1 has not previously been described in MCs.

There was also an increased enrichment score of the group containing the GO terms MC degranulation, leukocyte degranulation, and MC activation involved in immune response. This group also showed the highest fold enrichment. This MC lipid raft proteome consistently identified many of the proteins already described to be involved in MC degranulation, such as SNAREs (soluble N-ethylmaleimide-sensitive-factor attachment protein receptor), including VAMP (vesicle-associated membrane protein) 7 \[[@B110-ijms-20-03904]\], VAMP3, VAMP8 \[[@B110-ijms-20-03904],[@B111-ijms-20-03904]\], SNAP-23 (synaptosomal-associated protein 23) \[[@B110-ijms-20-03904],[@B112-ijms-20-03904]\], Syntaxin 3 \[[@B113-ijms-20-03904]\], and Syntaxin 4 \[[@B113-ijms-20-03904]\]. In addition to the accessory proteins the RAB GTPases (RAB3D, RAB5, RAB7, RAB9A, RAB11, RAB27A, RAB27B, and RAB43) \[[@B114-ijms-20-03904],[@B115-ijms-20-03904],[@B116-ijms-20-03904]\], syntaxin-binding protein 2 (MUC18-2) \[[@B113-ijms-20-03904]\], α-SNAP (alpha-soluble NSF attachment protein) \[[@B93-ijms-20-03904]\], and syntaxin-binding protein 5 (Tomosyn-1) \[[@B117-ijms-20-03904]\] were also identified.

The functionally related group that includes the GO terms positive regulation of signaling, positive regulation of cell communication, positive regulation of signal transduction was also enriched. Cell membrane lipids and lipid raft proteins have been implicated in various signaling events, including those dependent on the immunoglobulin-receptor superfamily in immune cells \[[@B18-ijms-20-03904],[@B32-ijms-20-03904],[@B80-ijms-20-03904],[@B118-ijms-20-03904]\]. In MCs, the events immediately following FcεRI activation that result in downstream signaling are still not completely understood \[[@B32-ijms-20-03904],[@B87-ijms-20-03904],[@B92-ijms-20-03904]\]. However, it is known that the aggregated receptors are translocated into lipid rafts where the SFKs are activated with subsequent phosphorylation of the receptor subunits \[[@B32-ijms-20-03904],[@B87-ijms-20-03904],[@B88-ijms-20-03904]\]. The N-terminal sequences of SFKs allow them to anchor to saturated fatty acid derivatives in the inner leaflet of the plasma membrane, enabling their partitioning into lipid rafts \[[@B119-ijms-20-03904],[@B120-ijms-20-03904]\]. Five of the eight members of SFKs, including Lyn, Fyn, Yes, Fgr, and Lck, were identified in this lipid raft proteome from non-activated RBL-2H3 MCs.

4. Conclusions {#sec4-ijms-20-03904}
==============

Based on the present data, a comprehensive study of the MC lipid raft proteome provides strong evidence that our two methods increased the proteome coverage and improved the identification of integral and associated lipid raft proteins. These proteins are involved in various aspects of MC function, especially those related to MC regulated secretion, organization and stabilization of macromolecules complexes, and signal transduction pathways. Thus, this identification of the raft membrane proteins could provide important tools for further investigation of molecular mechanisms related to the immunoregulatory functions of MCs.

5. Materials and Methods {#sec5-ijms-20-03904}
========================

5.1. Cell Culture {#sec5dot1-ijms-20-03904}
-----------------

RBL-2H3, a rat MC line \[[@B42-ijms-20-03904]\], was grown as monolayers in Dulbecco's Minimum Essential Medium (DMEM) supplemented with 15% fetal calf serum and an antibiotic-antimycotic mixture (100 U/mL penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL amphotericin B) in a humidified environment containing 5% CO~2~ in air at 37 °C. All reagents used for the cell culture were purchased from ThermoFisher Scientific (Thermo Fisher Scientific, Invitrogen, Carlsbad, CA, USA).

5.2. Isolation of Lipid Rafts from RBL-2H3 Mast Cells {#sec5dot2-ijms-20-03904}
-----------------------------------------------------

The lipid rafts were isolated using sucrose density-gradient ultracentrifugation, essentially as previously described \[[@B120-ijms-20-03904]\]. Briefly, (3--5) × 10^7^ RBL-2H3 MCs were plated in 150 mm tissue culture dishes (Corning Incorporated - Life Sciences, Oneonta, NY, USA). After 24 h, the cells were washed twice with ice-cold PBS and harvested and lysed on ice with 0.05% Triton X-100 (*v*/*v*) in 2.6 mL ice-cold MES buffer (25 mM 2-(4-Morpholino) ethane sulfonic acid, pH 6.5, 150 mM NaCl, 5 mM EDTA, and 1 mM Na~3~VO~4~) containing 2 mM PMSF and 50 μL/mL protease inhibitor cocktail. All reagents were purchased from Millipore Sigma (St. Louis, MO, USA). The resulting suspension was then homogenized 30 times on ice using a Dounce homogenizer with a tight-fitting piston, followed by incubation on ice for 15 min. The lysates were then centrifuged for 10 min at 900× *g* and the 2.6 mL of supernatant was overlaid on 2.6 mL 80% sucrose (*w*/*v*) in a MES buffer in the bottom of a 13 mL Beckman centrifuge tube (Beckman Coulter, Fullerton, CA, USA) and gently vortexed to give the final concentration of 40% sucrose. Thereafter, the sample was overlaid with 5.2 mL of 35% sucrose (*w*/*v*) in lysis buffer. Then, 2.6 mL 5% sucrose (*w*/*v*) in lysis buffer was added on top to form a discontinuous gradient. Samples were centrifuged using a Beckman SW40Ti rotor (Beckman Coulter) at 38,000 rpm for 20 h at 4 °C. Fractions 1.3 mL in volume were collected from the top of the tube.

5.3. Immunoblotting Analysis of Lipid Raft Enriched Fractions {#sec5dot3-ijms-20-03904}
-------------------------------------------------------------

In order to localize the lipid rafts in the gradient fractions, 5 μL from each fraction were immobilized on Hybond membranes (GE Healthcare Life Sciences, Marlborough, MA, USA) using the vacuum microfiltration system Bio Dot (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The membranes were immunoblotted as previously described \[[@B121-ijms-20-03904]\]. The following primary antibodies were used: goat polyclonal antibody anti-mouse LAT (Clone Q-20) (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), rabbit polyclonal antibody anti-human Lyn (Clone 44 sc-15) (Santa Cruz Biotechnology Inc.), mouse mAb anti-FcεRI beta subunit antibodies generously provided by Dr. Reuben Siraganian (NIH---NIDCR, Bethesda, MD, USA), rabbit polyclonal antibody anti-human Flotillin-1 (ab41927) and rabbit polyclonal antibody anti-human Histone H3 (ab1791) (Abcam, Cambridge, MA, USA), and mouse monoclonal antibody anti-rat GD1b derived gangliosides (Clone AR32AA4) (BD Pharmingen, San Jose, CA, USA). The secondary antibodies used were donkey anti-goat IgG conjugated to horseradish peroxidase (HRP), donkey anti-rabbit IgG conjugated to HRP, and donkey anti-mouse IgG conjugated to HRP (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA). The membranes were developed using enhanced chemiluminescence (ECL Kit; GE Healthcare) and the images were obtained with ImageQuant LAS 4000 (GE Healthcare).

5.4. Extraction and Digestion of Mast Cell Lipid Raft Proteins for Mass Spectrometry {#sec5dot4-ijms-20-03904}
------------------------------------------------------------------------------------

The lipid raft enriched fractions (the low-density Fractions 2 and 3) obtained from three independent experiments were pooled and the sample was used for two different post-isolation treatment methods. In MetI, the samples were mixed with ice-cold 50 mM NH~4~HCO~3~ (Millipore Sigma) pH 7.9, washed, and concentrated using an Amicon^®^ Ultra-3 Centrifugal Filter (Merk Millipore, Burlington, MA, USA). In MetII, the pooled fractions were gently mixed with ice-cold MNE-buffer (25 mM MES, pH 6.5; 5 mM EDTA; 150 mM NaCl) and pelleted using centrifugation (200,000 × *g*, 1 h). Samples were subsequently mixed with 100 µL of 100 mM n-octyl-beta-D-gluco-pyranoside (OGP) followed by methanol-chloroform extraction as previously described \[[@B74-ijms-20-03904]\].

For both methods, the proteins were enzymatically digested as described previously \[[@B122-ijms-20-03904],[@B123-ijms-20-03904]\] with some modifications. Briefly, the protein content was quantified using the Bradford reagent (Millipore Sigma), and bovine serum albumin (BSA; Millipore Sigma) was used as a standard \[[@B124-ijms-20-03904]\]. Then, 50 μg of protein from each method was added to 10 mL of 50 mM ammonium bicarbonate, pH 8.5. Then, 25 μL of RapiGEST^TM^ SF Surfactante (0.2% *v*/*v*) (Waters, Milford, PA, USA) was added, and the sample was vortexed and then incubated at 80 °C for 15 min. The sample was reduced via incubation with 2.5 μL of 100 mM dithiothreitol (DTT) (GE Healthcare) at 60 °C for 30 min and cysteine alkylation was done by incubating the samples with 2.5 μL of 300 mM iodocetamide (GE Healthcare) for 30 min at room temperature in the dark. The proteins were subsequently digested with 10 μL of trypsin (0.05 mg/μL; Promega, Madison, WI, USA) at 37 °C for 16 h. The samples were subsequently acidified with 10 μL of 5% trifluoracetic acid (*v*/*v*) (Millipore Sigma), followed by incubation at 37 °C for 90 min in order to stop the trypsin digestion and precipitate the RapiGEST™ SF Surfactante, and centrifugation at 21,000× *g* at 4 °C for 30 min was carried out. The supernatants were dried in a Savant™ SpeedVac™ Concentrator (ThermoFisher Scientific), and all obtained peptides were suspended in 49.5 μL of a solution containing 20 mM ammonium formate and 100 fmol/μL yeast enolase (MassPREP^TM^ protein; Waters) as an internal standard.

5.5. Nano-Electrospray Ionization Source (ESI) and Ultra-Performance Liquid Chromatography Mass Spectrometry (UPLC-MS^E^) {#sec5dot5-ijms-20-03904}
-------------------------------------------------------------------------------------------------------------------------

Nanoscale LC separation of tryptic peptides was performed using a nanoACQUITY^TM^ system (Waters) equipped with a nanoEase^TM^ 5 mm × Bridge^TM^ BEH130 C18 300 mm × 50 mm precolumn; trap column 5 mm, 180 mm × 20 mm; and BEH130 C18 1.7 mm, 100 mm × 100 mm analytical reversed-phase column (Waters). The peptides were separated into 10 fractions and the gradient elution was performed as follows: 8.7, 11.4, 13.2, 14.7, 16, 17.4, 18.9, 20.7, 23.4, and 65% acetonitrile/0.1% (*v*/*v*) formic acid, with a flow rate of 2000 mL/min. The source was operated in positive ionization mode nano-ESI (+). GFP \[Glu\]^1^-fibrinopeptide B human (\[MC2H\]^2+^ = 785.8426) (Millipore Sigma) was used for lock mass calibration of the apparatus, using a constant flow rate of 0.5 μL/min at a concentration of 200 fmol protein. MS analysis was performed on a Synapt G1 MS^TM^ (Waters) equipped with a NanoElectronSpray source and two mass analyzers: a quadrupole and a time-of-flight (TOF) operating in V-mode. The mass spectrometer was programmed in the data-dependent acquisition mode, in which a full scan in the m/z region of 50--2000 was used. Data were obtained using the instrument in the MS^E^ mode, which switched between the low energy (6 V) and elevated energy (40 V) acquisition modes every 0.4 s. Samples were analyzed using three replicates.

5.6. Data Processing and Protein Identification Analysis {#sec5dot6-ijms-20-03904}
--------------------------------------------------------

The acquired MS raw data were processed using the ProteinLynx Global Server version 2.4 (PLGS) (Waters). The data were subjected to automatic background subtraction, deisotoping, and charge state deconvolution. After processing, each ion comprised an exact mass-retention time (EMRT) that contained the retention time, intensity-weighted average charge, inferred molecular weight based on charge, and m/z. The processed spectra were searched against *Rattus norvegicus* entries (29,952 sequences) from the UniProt database (<http://www.uniprot.org>). The mass error tolerance for peptide identification was under 50 ppm. The parameters for protein identification included: (I) the detection of at least two fragment ions per peptide; (II) five fragments per protein; (III) the determination of at least one peptide per protein; (IV) carbamidomethylation of cysteine as a fixed modification; (V) phosphorylation of serine, threonine, and tyrosine, and oxidation of methionine were considered as variable modifications; (VI) maximum protein mass (600 kDa); (VII) one missed cleavage site was allowed for trypsin; (VIII) and a maximum false positive ratio (FDR) of 4% was allowed. The minimum repeat rate for each protein in all replicates was two. The protein table was compared using the Spotfire^®^ v8.0 software, and graphs were generated for all data.

5.7. Bioinformatics Analysis {#sec5dot7-ijms-20-03904}
----------------------------

To detect the co-differentially presented protein in our data sets, we performed a comparative analysis of the overlaps using Venn diagrams (<http://bioinformatics.psb.ugent.be/webtools/Venn/>). RaftProtV2 database (<http://raftprot.org>) was used to systematically analyze the known lipid raft proteins \[[@B26-ijms-20-03904]\]. Since proteomes of rat lipid rafts correspond to less than 13% of the included data \[[@B26-ijms-20-03904]\], data obtained from human and mouse lipid raft proteomes was also used in this analysis.

The graph of experimentally determined lipid modification types was generated using PhosphoSitePlus (<http://www.phosphosite.org>) \[[@B125-ijms-20-03904]\]; SwissPalm (http://www.swisspalm.org) \[[@B126-ijms-20-03904]\]; PRENbase (<http://mendel.imp.ac.at/PrePS/PRENbase>) \[[@B127-ijms-20-03904]\]; MYRbase (<http://mendel.imp.ac.at/myristate/myrbase>) \[[@B128-ijms-20-03904]\]; and PredGPI (<http://gpcr.biocomp.unibo.it/predgpi>) \[[@B129-ijms-20-03904]\]. In order to systematically investigate the denaturing properties of the applied methods, an analysis of potential transmembrane domains (TMD) was conducted using TMHMM 2.0 (<http://www.cbs.dtu.dk/services/TMHMM/>) on the complete data set \[[@B130-ijms-20-03904],[@B131-ijms-20-03904]\].

Gene Ontology (GO) annotation charts based on the complete list of UniProt Knowledgebase accession entries were generated using STRAP (Software Tool for Researching Annotations of Proteins) \[[@B49-ijms-20-03904]\]. The Database for Annotation Visualization and Integrated Discovery (DAVID; <http://david.ncifcrf.gov>), version 6.8, National Institute of Allergy and Infectious Diseases \[[@B50-ijms-20-03904]\], was used for enrichment analysis, enrichment scores for annotation groups, and fold enrichment factors for individual GO terms, as well as Fisher's exact *p*-values and false discovery rates (FDR) using Benjamini--Hochberg coefficients, adjusting for multiple comparisons.
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![Identification of RBL-2H3 mast cell lipid rafts. Lysates of RBL-2H3 MCs were fractionated using sucrose density gradient ultracentrifugation, and fractions were immunoblotted using antibodies against lipid raft markers: LAT1, SFK Lyn, rodent MC-specific GD1b-derived gangliosides, and Flotillin-1. Proteins and lipids associated with lipid rafts were concentrated in Fractions 2 and 3. Fractions were also immunoblotted with anti-Histone H3, a nuclear protein. Data representative of three independent experiments is shown.](ijms-20-03904-g001){#ijms-20-03904-f001}

![Proteomic identification of lipid raft enriched fractions of RBL-2H3 mast cells. MC lipid-raft-enriched Fractions 2 and 3 were used for Nano-UPLC-MS^E^ analysis. A Venn diagram depicting the number of overlapping and unique proteins present in MC lipid rafts processed using Method I (MetI) and Method II (MetII) is shown.](ijms-20-03904-g002){#ijms-20-03904-f002}

![Proteins with an annotated lipid modification identified in mast cell lipid rafts isolated using Method I or Method II. Databases used: PhosphoSitePlus, SwissPalm, MYRbase, PRENbase, and PredGPI.](ijms-20-03904-g003){#ijms-20-03904-f003}

![Analysis of transmembrane domain (TMD) present in unique and common mast cell lipid raft proteins identified using Method I or Method II. Prediction of the presence of TMD was done using the TMHMM server v2.0. (**A**) Number of proteins with and without TMDs is shown. (**B**) The number of proteins with TMD versus the number of TMD/protein is given.](ijms-20-03904-g004){#ijms-20-03904-f004}

![Graphical representation of the GO classes of biological domains association data with the 949 proteins identified in mast cell lipid rafts as annotated by STRAP. Identified proteins were grouped according to the three main GO classes: (**A**) cellular component, (**B**) biological processes, and (**C**) molecular function. The data is expressed as a percentage of proteins associated with each GO term.](ijms-20-03904-g005){#ijms-20-03904-f005}

![Analysis of unique and common proteins localized in mast cell lipid rafts isolated with MetI or MetII. The unique and common proteins identified using MetI and MetII in lipid rafts from RBL-2H3 MCs were analyzed according to the three main GO classes: (**A**) cellular component, (**B**) biological processes, and (**C**) molecular function. Data for the unique and common proteins identified using MetI and MetII in lipid rafts from RBL-2H3 MCs was annotated using STRAP.](ijms-20-03904-g006){#ijms-20-03904-f006}

![Functional relationship among the proteins and their associated GO terms in the mast cell lipid raft proteome. Groups with the highest enrichment scores following analysis using DAVID are shown. The enrichment score groups (brown rectangles) and non-grouped terms (blue rectangle) are indicated according to their biological significance. The fold enrichment factor (orange bars) is also shown. Data was analyzed using the DAVID Bioinformatics Resources database.](ijms-20-03904-g007){#ijms-20-03904-f007}
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###### 

Mast cell lipid raft proteins annotated with the highest number of citations supported by experimental evidence in RaftProtV2 database.

  Method        Protein Accession   Protein Description                                       Gene Name   Experimental Evidence   Number of Citations
  ------------- ------------------- --------------------------------------------------------- ----------- ----------------------- ---------------------
  MetII         P63018              Heat shock cognate 71 kDa protein                         Hspa8       H (3) M (3) R (3)       102
  MetII         Q9Z1E1              Flotillin-1                                               Flot1       H (3) M (1) R (3)       101
  MetI; MetII   P15999              ATP synthase subunit alpha mitochondrial                  Atp5fla     H (3) M (3) R (3)       98
  MetI          P10719              ATP synthase subunit beta mitochondrial                   Atp5f1b     H (1) M (1) R (3)       97
  MetI; MetII   Q9Z2L0              Voltage-dependent anion-selective channel protein 1       Vdac1       H (3) M (3) R (3)       97
  MetI; MetII   P67779              Prohibitin                                                Phb         H (3) M (1) R (1)       91
  MetI; MetII   P60711              Actin cytoplasmic 1                                       Actb        H (3) M (3) R (3)       90
  MetII         Q9Z2S9              Flotillin-2                                               Flot2       H (3) M (3) R (3)       90
  MetI; MetII   P81155              Voltage-dependent anion-selective channel protein 2       Vdac2       H (3) M (3) R (1)       90
  MetI; MetII   P06685              Sodium/potassium-transporting ATPase subunit alpha-1      Atp1a1      H (1) M (1) R (1)       89
  MetI; MetII   P04797              Glyceraldehyde-3-phosphate dehydrogenase                  Gapdh       H (1) M (1) R (1)       88
  MetI; MetII   P54311              Transducin beta-1                                         Gnb1        H (3) M (3) R (3)       87
  MetI          Q07936              Annexin A2                                                Anxa2       H(1) M (3) R (3)        86
  MetI; MetII   P04897              Guanine nucleotide-binding protein G(i) subunit alpha-2   Gnai2       H (3) M (3) R (3)       86
  MetI; MetII   P06761              Endoplasmic reticulum chaperone BiP                       Hspa5       H (1) M (1) R (1)       86
  MetI; MetII   P35565              Calnexin                                                  Canx        H (1) M (1) R (1)       83
  MetI; MetII   G3V6P7              Myosin heavy chain 9                                      Myh9        H (3) M (3)             83
  MetI          P31000              Vimentin                                                  Vim         H (3) M (3) R (3)       81
  MetI; MetII   P09527              Ras-related protein Rab-7a                                Rab7a       H (1) M (1) R (1)       79
  MetI; MetII   P26453              Basigin                                                   Bsg         H (3) M (3) R (3)       78
  MetI; MetII   D4A133              V-type proton ATPase catalytic subunit A                  Atp6v1a     H (3) M (3)             78
  MetI; MetII   P63102              14-3-3 protein zeta/delta                                 Ywhaz       H (1) M (1) R (1)       77
  MetI; MetII   P11442              Clathrin heavy chain 1                                    Cltc        H (3) M (3) R (3)       77
  MetII         F1M779              Clathrin heavy chain                                      Cltc        H (3) M (3) R (3)       77
  MetII         Q5XI04              Erythrocyte band 7 integral membrane protein              Stom        H (1) M (1)             77
  MetI; MetII   P54313              Transducin beta-2                                         Gnb2        H (3) M (3) R (3)       76
  MetII         B5DEH2              Erlin-2                                                   Erlin2      H (3) M (3) R (3)       74
  MetII         O70377              Synaptosomal-associated protein 23 (SNAP-23)              Snap23      H (3) M (3) R (3)       74
  MetI; MetII   P32551              Cytochrome b-c1 complex subunit 2 mitochondrial           Uqcrc2      H (3) M (3) R (3)       72
  MetI; MetII   Q5XIH7              Prohibitin 2                                              Phb2        H (3) M (3) R (3)       71

Method---Post-isolation treatment method; Protein accession---UniProt protein accession number; Protein description---Functional description; Gene name---Name of gene that codes for the protein sequence; Experimental evidence---Experimental data validating inclusion as a lipid raft protein; (1) indicates protein identification by more than one biochemical extraction method; (3) indicates fulfillment of criteria (1) and the sensitivity to more than one raft perturbation technique; Number of citations---Number of studies with supporting experimental evidence describing the lipid raft protein; H---Human; M---Mouse; R---Rat.
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###### 

Highest percentage of annotated proteins within each GO term.

  GO Term                             Unique MetI   Unique MetII   Common
  ----------------------------------- ------------- -------------- --------
  **Cellular Component Class**                                     
  Cell surface                                                     **+**
  Cytoplasm                           **+**                        
  Cytoskeleton                        **+**                        **+**
  Endoplasmic reticulum                             **+**          
  Endosome                                          **+**          
  Extracellular                       **+**                        
  Macromolecular complex              **+**                        
  Mitochondria                                                     **+**
  Nucleus                             **+**                        
  Other                                             **+**          
  Other intracellular organelles                    **+**          
  Plasma membrane                                                  **+**
  Ribosomes                                         **+**          
  **Biological Processes Class**                                   
  Cellular process                                  **+**          
  Immune system process                             **+**          **+**
  Interaction with cells/organelles                                **+**
  Localization                                      **+**          
  Metabolic process                   **+**                        
  Other                               **+**                        
  Regulation                          **+**                        
  Response to stimulus                **+**                        
  **Molecular Function Class**                                     
  Binding                             **+**                        
  Catalytic activity                                **+**          
  Molecular transducer activity                     **+**          
  Other                                                            **+**
  Structural molecular activity                                    **+**
